Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Sep;10(3):287-92.
doi: 10.1111/j.1365-2125.1980.tb01757.x.

Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes

Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes

L Fletcher et al. Br J Clin Pharmacol. 1980 Sep.

Abstract

1 A specific assay for the measurement of thioinosinic acid, in human lymphocytes, has been developed with a sensitivity of 50 ng of thioinosinic acid per 5 x 10(6) lymphocytes. 2 Thioinosinic acid is precipitated from purified lymphocytes as the lanthanum salt. Acid hydrolysis results in the formation of 6-mercaptopurine which, when converted into its phenyl mercury derivative, can be easily extracted into toluene. Back-extraction of the toluene layer with 0.1N HCl regenerates 6-mercaptopurine which is then assayed fluorometrically. 3 Blood samples were taken from renal transplant recipients 3 h after an oral dose of 50 mg azathioprine. The results from 5 patients gave a range of 54 to 173 ng of thioinosinic acid per 5 x 10(6) lymphocytes, with a mean of 110 ng. 4 In an in vitro incubation of azathioprine, 1mM with fresh human blood, 160 and 180 ng of thioinosinic acid per 5 x 10(6) lymphocytes was formed after 0.5 h and 5 h respectively. 5 The assay is suitable for the study of the kinetics of thioinosinic acid formation in lymphocytes of patients with kidney transplants. It could also prove useful in the study of thioinosinic acid formation in leukaemia patients undergoing 6-mercaptopurine treatment.

PubMed Disclaimer

References

    1. Adv Chemother. 1965;2:91-177 - PubMed
    1. Fed Proc. 1967 May-Jun;26(3):898-904 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. J Chromatogr. 1969 Oct 28;44(2):331-41 - PubMed
    1. J Chromatogr. 1973 Mar 14;77(1):181-90 - PubMed

Publication types

LinkOut - more resources